Paul Jenkins has been named global vice president Business Development, Zydis Technology at Catalent Pharma Solutions. In this role, Dr. Jenkins will be responsible for expanding Catalent’s business growth in fast-dissolve technology across the world. He will be based in Swindon, UK.   Prior to joining Catalent, Dr. Jenkins was the chief executive officer of Adjuvantix, a UK-based biotechnology company, where he was responsible for all commercial activities and external funding.  Prior to that, ...